Related Experiment Video

Updated: Aug 27, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.7K

Heart failure in general and cardiac transplant patients with COVID-19

Munish Sharma1, Gowthami Sai Kogilathota Jagirdhar2, Kalpalatha K Guntupalli3

  • 1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States.

World Journal of Cardiology
|September 26, 2022
PubMed

Insights

Coronavirus disease 2019 (COVID-19) can cause heart failure (HF), either new or worsening existing conditions. Managing HF in COVID-19 patients is crucial for their prognosis.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Internal Medicine

Background:

  • COVID-19 primarily affects the respiratory system but has multisystem implications.
  • Cardiac complications are common in COVID-19, including acute myocardial injury, arrhythmias, and heart failure.
  • Heart failure (HF) in COVID-19 can be a new diagnosis or an exacerbation of pre-existing cardiovascular disease.

Purpose of the Study:

  • To review the impact of the COVID-19 pandemic on patients with pre-existing or new-onset heart failure.
  • To summarize current data on the clinical presentation and management of heart failure in the context of COVID-19.
  • To provide insights into special recommendations for managing heart failure during the pandemic.

Main Methods:

  • Literature review of prevailing data and prior studies.
  • Analysis of clinical presentation and management challenges.
  • Synthesis of guidelines and recommendations.

Main Results:

  • COVID-19 poses significant challenges to the management of heart failure patients.
  • Multisystem manifestations of COVID-19 can complicate cardiac care.
  • Prognosis is affected by the interplay between COVID-19 and heart failure.

Conclusions:

  • Heart failure is a critical consideration in COVID-19 patient care.
  • Effective management strategies are essential for improving outcomes.
  • Further research and updated guidelines are needed to address HF in COVID-19.

Keywords:
COVID-19CardiomyopathyCoronavirusHeart failure

More Related Videos

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

947
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

414

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
44
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21